FDA to require new safety warnings for opioids
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy